Evaluation of sequential intermittent pneumatic compression for filarial lymphoedema
- PMID: 12296471
Evaluation of sequential intermittent pneumatic compression for filarial lymphoedema
Abstract
Background: Lymphoedema is a major cause of morbidity in patients with lymphatic filariasis. There is no effective medical treatment and the results of surgery are uncertain. There are very few published studies assessing the volumetric response to the use of sequential intermittent pneumatic compression (SIPC) in patients.
Methods: A 12-celled instrument capable of providing sequential compression from the distal to proximal direction was used in 28 patients with unilateral grades II (n=17) and III (n=11) filarial lymphoedema in a planned 4-week session. The patients were followed up for 6 months after compression therapy by water displacement volumetry.
Results: We found that 12 patients with grade II filarial lymphoedema had >26% reduction in oedema volume immediately after compression, but this reduction (>26%) was maintained in only 7 at 6 months. The corresponding figures for grade III filarial lymphoedema were 6 and 4, respectively. The effect in grade III was less sustained than grade II. No complications attributable to SIPC were seen. An added advantage of SIPC was a significant decrease in attacks of adenolymphangitis after compression when compared to pre-compression frequency. These observations were seen even with non-compliance to both foot care measures and use of bandages to maintain reduction in oedema volume.
Conclusion: SIPC reduces morbidity in filarial lymphoedema though the effect is not sustained. It is simple, easy to use and could form part of the morbidity control programme for lymphatic filariasis.
Similar articles
-
A randomized clinical trial to compare the efficacy of three treatment regimens along with footcare in the morbidity management of filarial lymphoedema.Trop Med Int Health. 2005 Jul;10(7):698-705. doi: 10.1111/j.1365-3156.2005.01442.x. Trop Med Int Health. 2005. PMID: 15960709 Clinical Trial.
-
Factors influencing response to lymphonodovenous shunt in filarial lymphoedema.Natl Med J India. 1999 Mar-Apr;12(2):55-8. Natl Med J India. 1999. PMID: 10416319 Clinical Trial.
-
A survey on foot care practices among filarial lymphoedema patients in Orissa, India.Trop Biomed. 2007 Dec;24(2):7-14. Trop Biomed. 2007. PMID: 18209702
-
Management of disability in lymphatic filariasis--an update.J Commun Dis. 2002 Mar;34(1):1-14. J Commun Dis. 2002. PMID: 12718336 Review.
-
Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.Trends Parasitol. 2006 Jul;22(7):340-4. doi: 10.1016/j.pt.2006.05.010. Epub 2006 May 19. Trends Parasitol. 2006. PMID: 16713740 Review.
Cited by
-
Serum Lipid Changes after Short Term SIPC Therapy for Lower Limb Lymphedema.Indian J Surg. 2010 Aug;72(4):305-7. doi: 10.1007/s12262-010-0211-4. Epub 2010 Nov 23. Indian J Surg. 2010. PMID: 22282316 Free PMC article.
-
Some observations on the effect of Daflon (micronized purified flavonoid fraction of Rutaceae aurantiae) in bancroftian filarial lymphoedema.Filaria J. 2003 Mar 12;2(1):5. doi: 10.1186/1475-2883-2-5. Filaria J. 2003. PMID: 12691606 Free PMC article.